New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
06:51 EDTCBRX, ACTColumbia Laboratories repurchases 1.4M shares of common stock from Actavis
Columbia Laboratories (CBRX) announced that the company has repurchased 1.4 million shares of its common stock, par value 1c per share, from Coventry Acquisition, a subsidiary of Actavis (ACT) at $6.08 per share, which represents a 10.75% discount to the closing price on March 6. The total purchase price was approximately $8.5M. This transaction reduces the total issued and outstanding shares of common stock by about 11.5% from approximately 12.15M to 10.75M.
News For CBRX;ACT From The Last 14 Days
Check below for free stories on CBRX;ACT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
07:08 EDTCBRXColumbia Laboratories subsidiary partners with Xenogesis
Subscribe for More Information
07:06 EDTCBRXColumbia Laboratories CEO sees Q3 revenues improving
Columbia Laboratories (CBRX) CEO stated, "The routine license renewal by Merck (MRK) Serono for one of its high-volume, high-margin markets is expected to be complete in 2H14, whereupon normal shipments will then resume at the beginning of 2015. The new license will be in place for five years, thereby restoring the predictability of this long-term revenue stream. In the interim, Merck Serono placed an order with us as part of a one-time exception during the renewal process. The order will be shipped in Q3 and benefit that quarter's revenues. In terms of the services business, we expect a sequential improvement in Q3 revenues due to successful recent business development activities and customer interest in our comprehensive suite of advanced technologies."
07:03 EDTCBRXColumbia Laboratories reports Q2 EPS 1c, one estimate 11c
Subscribe for More Information
July 23, 2014
10:02 EDTACTOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:10 EDTACTDeutsche Bank hosts an analyst Specialty Pharma/Industry conference call
Subscribe for More Information
July 22, 2014
16:09 EDTACTActavis initiated with a Buy at Deutsche Bank
Subscribe for More Information
July 21, 2014
16:36 EDTACTActavis and Medicines360 announce FDA acceptance of Levosert NDA
Subscribe for More Information
July 17, 2014
15:42 EDTACTDepomed says Actavis preliminarily enjoined from marketing generic Gralise
Subscribe for More Information
08:34 EDTCBRXColumbia Laboratories awarded U.S. patent for hydration tablets
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use